https://www.selleckchem.com/pr....oducts/Cediranib.htm
A diagnosis of gastroesophageal reflux disease is challenging in patients who have reflux symptoms but do not respond to proton pump inhibitors nor have reflux esophagitis and hiatal hernia (HH) on endoscopy. This study examined the predictive role of the endoscopic findings, including the flap valve grade for pathologic acid exposure (PAE) to establish an endoscopic prediction model in patients with neither reflux esophagitis nor HH. Five hundred seventy-eight patients who underwent upper endoscopy and 24 hours pH monitoring for refl
Like
Comment
Share
